MAPT and Alzheimer disease: Alzheimer’s disease (AD) is characterized by deposits of amyloid-β (Aβ) and hyperphosphorylated tau proteins that may impair neurovascular regulation, blood brain barrier (BBB) integrity9, and expression of glucose transporters at the BBB6.